COMMUNIQUÉS West-GlobeNewswire

Alzheimer's Data Challenge Names Winners for Innovative Biomarker Research Competition

27/03/2025 - 14:00

Global Researchers Recognized for Trailblazing Projects in First-of-Its-Kind Data Competition WASHINGTON, March 27, 2025 (GLOBE NEWSWIRE) -- International non-profit organization The Global Alzheimer’s Platform [...]

Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra

27/03/2025 - 14:00

INBS set to capitalize on growing Spanish Drug Testing Market, anticipated to reach $448 million by 2030 Major Spanish accounts currently require 1,000 drug testing cartridges per month NEW YORK, March 27, 2025 (GLOBE [...]

Prime Biome: Best Probiotic Supplement? Prime Biome Redefines the Skin-Gut Cell Turnover Approach

27/03/2025 - 13:55

Prime Biome is a science-backed probiotic that rejuvenates skin and supports digestion. Learn where to buy Prime Biome gummies. ST. PETERSBURG, Fla., March 27, 2025 (GLOBE NEWSWIRE) -- Prime Biome emerges as a science- [...]

Premier Health Announces CEO Departure

27/03/2025 - 13:32

MONTRÉAL, March 27, 2025 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA ) (the “ Corporation ”), a leading Canadian Healthtech company, announces that Martin Legault has resigned from his role as [...]

Oragenics, Inc. Provides Q1 2025 Shareholder Update on Strategic and Financial Progress

27/03/2025 - 13:30

ONP-002 Advances Toward Phase IIa Concussion Trial with Strengthened Financial Foundation and Industry Momentum SARASOTA, Fla., March 27, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology [...]

FibroBiologics Announces 2025 Annual Meeting of Stockholders

27/03/2025 - 13:30

HOUSTON, March 27, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of [...]

SS Innovations International, Inc. Achieves Another Milestone by Successfully Performing Over 2,000 km North-to-South Robotic Cardiac Telesurgery with its SSi Mantra 3 Surgical Robotic System

27/03/2025 - 13:30

The SSI Mantra 3 Surgical Robotic System enabled a seamless connection from SS Innovations headquarters in Gurugram, India to Aster CMI Hospital in Bengaluru, India covering a distance over 2,000 km. The SSi Mantra, [...]

Chemomab Reports Positive Results in Nebokitug Phase 2 PSC Open Label Extension Trial Showing Continued Broad and Substantial Improvements in Key Liver Biomarkers

27/03/2025 - 13:30

Reinforces potential of nebokitug to become the first approved drug with disease-modifying activity for PSC--a deadly disorder that currently has no effective treatments Treatment in PSC patients with moderate/advanced [...]

LIXTE Biotechnology Provides Update On Progress with Proprietary Compound, LB-100, to Treat Ovarian and Colorectal Cancer

27/03/2025 - 13:30

-Started Two New Clinical Trials, Collaborating with MD Anderson and The Netherlands Cancer Institute for Treatment of Ovarian and Colorectal Cancer- -Received Exclusive Patent License Agreement with the NIH on LB-100's [...]

ProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025

27/03/2025 - 13:27

GARDEN CITY, NY, March 27, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”), a next generation biotech, genomics and consumer products company, today announced that they will be [...]

Polyrizon Structures Clinical Strategy for its Allergy Blocker Ahead of FDA Pre-Submission Meeting

27/03/2025 - 13:25

Studies to assess efficacy, safety, user experience, and nasal residence time as Company prepares for regulatory path forward Raanana, Israel, March 27, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ), a biotech [...]

Third Harmonic Bio Announces Fourth Quarter and Full Year 2024 Financial Results

27/03/2025 - 13:10

Recently presented THB335 Phase 1 data support advancement into Phase 2 clinical trial in chronic spontaneous urticaria (CSU) Strategic alternatives process underway to maximize value creation across all assets in the [...]

Organovo Provides Business Update

27/03/2025 - 13:05

SAN DIEGO, March 27, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory [...]

Wellgistics Health Annual Letter to Shareholders From the Office of the CEO March 2025

27/03/2025 - 13:05

Dear Shareholders, TAMPA, FL, March 27, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ: WGRX) (“Wellgistics Health”), This time last year, Wellgistics was a private company, weathering the pressures of a [...]

AIM ImmunoTech Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

27/03/2025 - 13:05

Continued execution across Ampligen ® (rintatolimod) clinical development programs in areas with critical unmet needs, especially in the high-value pancreatic cancer space Expected milestones over the course of the next [...]

SpyGlass Pharma Appoints Chetan Pujara, Ph.D., as Chief Research & Development Officer

27/03/2025 - 13:00

Dr. Pujara brings extensive industry experience to guide late-stage development of the SpyGlass Drug Delivery Platform ALISO VIEJO, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- SpyGlass Pharma™, a privately-held [...]

Evaxion to announce business update and full year 2024 financial results on April 1, 2025

27/03/2025 - 13:00

COPENHAGEN, Denmark, March 27, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a business update and [...]

4DMT to Participate in Upcoming Investor Conferences

27/03/2025 - 13:00

EMERYVILLE, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with [...]

TIVDAK® (tisotumab vedotin) Approved by Japan Ministry of Health, Labour and Welfare for the Treatment of Advanced or Recurrent Cervical Cancer that has Progressed on or after Chemotherapy

27/03/2025 - 13:00

Media Release COPENHAGEN, Denmark; March 27, 2025 TIVDAK ® is the first and only antibody-drug conjugate (ADC) approved for patients with advanced or recurrent cervical cancer in Japan Approval is based on results from [...]